Optogenetic-controlled immunotherapeutic designer cells for post-surgical cancer immunotherapy
Work
Year: 2022
Type: article
Abstract: Surgical resection is the main treatment option for most solid tumors, yet cancer recurrence after surgical resection remains a significant challenge in cancer therapy. Recent advances in cancer immun... more
Source: Nature Communications
Institutions East China Normal University, Shanghai Jiao Tong University, Yangpu Hospital of Tongji University
Cites: 46
Cited by: 27
Related to: 10
FWCI: 3.436
Citation percentile (by year/subfield): 73.88
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
APC paid (est): $4,808
Funders National Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality
Grant IDS no. 31971346, no. 22N31900300